# Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment

> **NCT00167557** · PHASE4 · WITHDRAWN · sponsor: **The University of Texas Health Science Center, Houston**

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Pegylated Interferon
- **DRUG:** Ribavirin
- **PROCEDURE:** Liver Biopsy

## Key facts

- **NCT ID:** NCT00167557
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-01
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The PI left the institution.
- **Last updated:** 2013-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00167557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00167557, "Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00167557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*